Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 15;29(2):020706.
doi: 10.11613/BM.2019.020706.

Optimizing laboratory defined macroprolactin algorithm

Affiliations

Optimizing laboratory defined macroprolactin algorithm

Milica Šostarić et al. Biochem Med (Zagreb). .

Abstract

Introduction: Macroprolactinaemia is a well-known analytical problem in diagnostics of hyperprolactinaemia usually detected with polyethylene glycol (PEG) precipitation method. Since there is no harmonization in macroprolactin detection and reporting results, this study proposes and evaluates the usefulness of in-house developed algorithm. The aims were to determine the most suitable way of reporting results after PEG treatment and the possibilities of rationalizing the precipitation procedure.

Materials and methods: This is a retrospective study based on extracted data for 1136 patients. Prolactin concentrations were measured before and after PEG precipitation on Roche cobas e601. Macroprolactinaemia was defined by percentage recovery and post-PEG prolactin concentrations.

Results: Prevalence of macroprolactinaemia using recovery criteria of ≤ 40%, ≤ 60%, and post-PEG prolactin concentrations was 3.3%, 8.8% and 7.8%, respectively. Raising the cut-off value from the upper limit of the manufacturer's reference interval to 32.9 µg/L does not drastically change detected macroprolactinaemia with recovery criteria. Post-PEG prolactin concentrations showed more than half of the patients with macroprolactinaemia would be overlooked. Regardless of the criteria, a cut-off of 47.0 µg/L would miss most of the macroprolactinaemic patients. Repeated recovery measurements of follow-up patients showed there is a significant difference with mean absolute bias of 9%.

Conclusions: Post-PEG prolactin concentration with corresponding reference interval is the most suitable way of reporting results. All samples with prolactin concentration above the upper limit of the manufacturer's reference interval should be submitted to PEG precipitation. Follow-up period could be prolonged since the difference between the recoveries of repeated measurements is not clinically significant.

Keywords: hyperprolactinaemia; macroprolactin; polyethylene glycol; prolactin.

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest: None declared.

Figures

Figure 1
Figure 1
An algorithm with criteria for polyethylene glycol (PEG) precipitation of macroprolactin. *repeated precipitation protocol on samples without fulfilled criteria was carried out by authorized personnel. Prl - prolactin.
Figure 2
Figure 2
Distribution of patients according to prolactin percentage recovery and post-PEG prolactin values. RI – post-PEG PRL reference interval (men: 3.0-11.5 µg/L; women: 3.5-17.9 µg/L).
Figure 3
Figure 3
Percentage of patients with macroprolactinaemia depending on the proposed cut-off values and different criteria for determining macroprolactinaemia. ULRI – initial prolactin upper limit of the reference interval (men: 15.2 µg/L; women: 23.3 µg/L). RI – post-PEG PRL reference interval (men: 3.0-11.5 µg/L; women: 3.5-17.9 µg/L).

Similar articles

Cited by

References

    1. Richa V, Rahul G, Sarika A. Macroprolactin; A Frequent Cause of Misdiagnosed Hyperprolactinemia in Clinical Practice. J Reprod Infertil. 2010;11:161–7. - PMC - PubMed
    1. Kasum M, Orešković S, Čehić E, Šunj M, Lila A, Ejubović E. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia. Taiwan J Obstet Gynecol. 2017;56:719–24. 10.1016/j.tjog.2017.10.002 - DOI - PubMed
    1. Hattori N, Nakayama Y, Kitagawa K, Li T, Inagaki C. Development of Anti-PRL (Prolactin) Autoantibodies by Homologous PRL in Rats: A Model for Macroprolactinemia. Endocrinology. 2007;148:2465–70. 10.1210/en.2006-1208 - DOI - PubMed
    1. Lippi G, Plebani M. Macroprolactin: searching for a needle in a haystack? Clin Chem Lab Med. 2016;54:519–22. 10.1515/cclm-2015-1283 - DOI - PubMed
    1. Hattori N, Aisaka K, Shimatsu A. A possible cause of the variable detectability of macroprolactin by different immunoassay systems. Clin Chem Lab Med. 2016;54:603–8. 10.1515/cclm-2015-0484 - DOI - PubMed